- Home
- ASST vs EDSA Comparison
ASST vs EDSA Comparison
Compare ASST & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASST
- EDSA
- Stock Information
- Founded
- ASST 2020
- EDSA 2015
- Country
- ASST United States
- EDSA Canada
- Employees
- ASST N/A
- EDSA N/A
- Industry
- ASST Computer Software: Prepackaged Software
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- ASST Technology
- EDSA Health Care
- Exchange
- ASST Nasdaq
- EDSA Nasdaq
- Market Cap
- ASST 7.2M
- EDSA 6.2M
- IPO Year
- ASST 2023
- EDSA N/A
- Fundamental
- Price
- ASST $0.66
- EDSA $2.43
- Analyst Decision
- ASST
- EDSA Strong Buy
- Analyst Count
- ASST 0
- EDSA 1
- Target Price
- ASST N/A
- EDSA $21.00
- AVG Volume (30 Days)
- ASST 11.1M
- EDSA 5.9M
- Earning Date
- ASST 04-01-2025
- EDSA 02-14-2025
- Dividend Yield
- ASST N/A
- EDSA N/A
- EPS Growth
- ASST N/A
- EDSA N/A
- EPS
- ASST N/A
- EDSA N/A
- Revenue
- ASST $501,584.00
- EDSA N/A
- Revenue This Year
- ASST N/A
- EDSA N/A
- Revenue Next Year
- ASST N/A
- EDSA N/A
- P/E Ratio
- ASST N/A
- EDSA N/A
- Revenue Growth
- ASST 93.55
- EDSA N/A
- 52 Week Low
- ASST $0.34
- EDSA $1.55
- 52 Week High
- ASST $4.25
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- ASST 49.90
- EDSA 56.54
- Support Level
- ASST $0.57
- EDSA $2.30
- Resistance Level
- ASST $0.73
- EDSA $4.49
- Average True Range (ATR)
- ASST 0.11
- EDSA 0.30
- MACD
- ASST -0.01
- EDSA 0.05
- Stochastic Oscillator
- ASST 33.03
- EDSA 22.56
About ASST Asset Entities Inc. Class B
Asset Entities Inc is an Internet company providing social media marketing, content delivery, and development and design services across Discord, TikTok, and other social media platforms. It has three categories of services: 1) provide subscription upgrades to premium content on investment education and entertainment servers on Discord. 2) codevelop and execute influencer social media and marketing campaigns for clients. 3) design, develop and manage Discord servers for clients under "AE.360.DDM" brand.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.